Cellworks Group's Series A Round

Cellworks Group raised a round of funding on April 14, 2009. Investors include Artiman Ventures.

Cellworks Group is a biopharmaceutical therapeutic design and development company based on platform predicting clinical outcomes. The company has designed therapies that are substantially derisked wit…

Articles about Cellworks Group's Series A Round: